Additionally, G6PD altered the dynamics of the cell cycle, aided cell proliferation and migration in vitro, and improved the formation of ccRCC in vivo, most likely by promoting Cyclin E1 and MMP9 expression. Here, G6PD is linked to nonpapillary renal cell carcinoma.